Sun Pharmaceutical Industries has dipped over 4% to Rs 576 after the US Food and Drug Administration (FDA) has issued an import alert for all products manufactured at its plant at Karkhadi, Gujarat.
The company manufactures API (Active Pharmaceutical Ingredients) and formulations at its Karkhadi unit.
An "import alert" results in the detention without physical examination of drugs from firms that have not met so-called good manufacturing practices, according to the FDA website.
The stock opened at Rs 609 and touched a low of Rs 566 on the BSE. A combined 4.2 million shares changed hands on the counter till 11000 hours on the BSE and NSE.
The company manufactures API (Active Pharmaceutical Ingredients) and formulations at its Karkhadi unit.
An "import alert" results in the detention without physical examination of drugs from firms that have not met so-called good manufacturing practices, according to the FDA website.
The stock opened at Rs 609 and touched a low of Rs 566 on the BSE. A combined 4.2 million shares changed hands on the counter till 11000 hours on the BSE and NSE.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%